Warfarin might raise the risk of joint replacement: study
The analysis in people with AF suggests a NOAC might be the better option for those at risk of osteoarthritis, authors say
![](https://images.media.ausdoc.com.au/wp-content/uploads/2022/08/25212214/rheumatology_articleimage_news_912x684px-2.jpg)
AusDoc brings you the latest news from the American College of Rheumatology virtual congress 2020.
Taking the vitamin K antagonist warfarin appears to raise the risk of having a knee or hip replacement by 57%, compared to being on a non-vitamin K oral anticoagulant (NOAC), a study shows.